Condition Lookup
Sub-Category:
Dialysis-Associated Complications
Number of Conditions: 3
Hemodialysis-Associated Amyloidosis
Specialty: Nephrology
Category: Dialysis and Transplant-Related Conditions
Sub-category: Dialysis-Associated Complications
Symptoms:
joint pain and stiffness; carpal tunnel syndrome; bone cysts; tendon rupture; systemic fatigue
Root Cause:
Accumulation of Beta 2-microglobulin protein in tissues due to inefficient clearance by long-term hemodialysis.
How it's Diagnosed: videos
Blood and urine tests for Beta 2-microglobulin levels, imaging studies (X-ray, CT, or MRI for bone cysts), and tissue biopsy confirming amyloid deposits.
Treatment:
Improved dialysis modalities (high-flux membranes or hemodiafiltration), reduction in dialysis vintage, and kidney transplantation if feasible.
Medications:
Medications are supportive and include nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and corticosteroids to manage inflammation. Additionally, erythropoiesis-stimulating agents (ESAs) can be prescribed to manage associated anemia.
Prevalence:
How common the health condition is within a specific population.
More common in patients undergoing long-term hemodialysis, with prevalence increasing significantly after 5-10 years of treatment.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Long duration of hemodialysis, older age, use of low-flux dialysis membranes, chronic inflammation.
Prognosis:
The expected outcome or course of the condition over time.
Improved with advances in dialysis technology but remains poor in advanced cases without transplantation. Kidney transplantation offers the best outcome.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Bone fractures, severe joint dysfunction, tendon ruptures, systemic amyloidosis affecting other organs (e.g., heart, gastrointestinal system).
Vascular Access Complications
Specialty: Nephrology
Category: Dialysis and Transplant-Related Conditions
Sub-category: Dialysis-Associated Complications
Symptoms:
swelling around the access site; infection (redness, warmth, drainage); pain at the access site; poor blood flow during dialysis; numbness or tingling in the hand or arm
Root Cause:
Issues with the vascular access used for hemodialysis, including stenosis, thrombosis, infection, or aneurysm formation.
How it's Diagnosed: videos
Clinical examination, Doppler ultrasound for blood flow assessment, and imaging studies such as angiography to evaluate stenosis or occlusion.
Treatment:
Management depends on the complication
Medications:
Antibiotics for infection (e.g., vancomycin or cefazolin ), anticoagulants such as heparin to manage thrombosis, and antiplatelet agents to prevent clot formation.
Prevalence:
How common the health condition is within a specific population.
One of the most common complications in patients undergoing long-term hemodialysis, affecting up to 25% of patients annually.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Diabetes, smoking, obesity, prolonged use of the same access site, and improper care of the vascular access.
Prognosis:
The expected outcome or course of the condition over time.
Generally good with timely treatment; delays can lead to significant morbidity, including loss of the access site or life-threatening infection.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Septicemia, loss of vascular access, upper limb ischemia, and increased mortality if not addressed.
Peritoneal Dialysis Infections
Specialty: Nephrology
Category: Dialysis and Transplant-Related Conditions
Sub-category: Dialysis-Associated Complications
Symptoms:
abdominal pain; cloudy peritoneal dialysis fluid; fever; nausea; redness or drainage at catheter site
Root Cause:
Bacterial or fungal infection of the peritoneal cavity, often caused by contamination during the exchange process or catheter-related issues.
How it's Diagnosed: videos
Analysis of peritoneal dialysis fluid for elevated white blood cell count and culture to identify the causative organism.
Treatment:
Antibiotics or antifungal agents administered intraperitoneally or intravenously, catheter removal if the infection is severe or recurrent, and temporary cessation of peritoneal dialysis.
Medications:
First-line treatments include intraperitoneal antibiotics such as vancomycin (for Gram-positive organisms) and ceftazidime (for Gram-negative organisms). Antifungal agents like fluconazole may be prescribed for fungal infections.
Prevalence:
How common the health condition is within a specific population.
Occurs in approximately 20-25% of peritoneal dialysis patients annually.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Poor hygiene during exchanges, diabetes, older age, use of a contaminated catheter, or a history of prior infections.
Prognosis:
The expected outcome or course of the condition over time.
Good with early and appropriate treatment; untreated or severe cases can lead to peritonitis and necessitate a switch to hemodialysis.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Adhesions, loss of peritoneal membrane function, sepsis, and eventual requirement for a new dialysis modality.